Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × SCLC × Carboplatin × Clear all

Phase

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 95 Lung Neoplasms 38 Breast Neoplasms 30 Triple Negative Breast Neoplasms 27 Ovarian Neoplasms 23 Squamous Cell Carcinoma of Head and Neck 18 Endometrial Neoplasms 17 Small Cell Lung Carcinoma 16 Neoplasms 14 Fallopian Tube Neoplasms 13 Head and Neck Neoplasms 12 Uterine Cervical Neoplasms 11 Neoplasm Metastasis 10 Colorectal Neoplasms 10 Prostatic Neoplasms 9 Esophageal Squamous Cell Carcinoma 9 Esophageal Neoplasms 9 Carcinoma, Transitional Cell 9 Carcinoma, Squamous Cell 9 Parkinson Disease 4, Autosomal Dominant Lewy Body 8 Recurrence 7 Urinary Bladder Neoplasms 6 Oropharyngeal Neoplasms 6 Carcinoma, Ovarian Epithelial 5 Adenocarcinoma of Lung 5 Stomach Neoplasms 4 Pancreatic Neoplasms 4 Neuroblastoma 4 Mesothelioma 4 Lymphoma, Large B-Cell, Diffuse 4

Interventions

atezolizumab 1 apatinib 1 Topotecan 1 Paclitaxel 1 Immune Checkpoint Inhibitors 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06179069 2025-08-15

A Study of ZL-1310 in Subjects With Small Cell Lung Cancer

Zai Lab (Hong Kong), Ltd.

Phase 1 Recruiting

SCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡